Covered recipient · General Payments record
ALI AZZAWI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$229.62
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.70 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Mylan Specialty L.P. | $57.26 | 3 |
| Janssen Pharmaceuticals, Inc | $39.60 | 2 |
| Acerta Pharma LLC | $24.76 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.70 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.35 | 1 |
| ABBVIE INC. | $15.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.03 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103258437 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.76 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105648678 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.35 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101772963 | CMS |
| Janssen Pharmaceuticals, Inc | $20.92 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078108546 | CMS |
| Janssen Pharmaceuticals, Inc | $18.68 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078108614 | CMS |
| Mylan Specialty L.P. | $18.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147366038 | CMS |
| Mylan Specialty L.P. | $18.75 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147367465 | CMS |
| Mylan Specialty L.P. | $19.76 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147365189 | CMS |
| Novartis Pharmaceuticals Corporation | $24.70 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086778049 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.